|
|
|
|
| LEADER |
00949nam a2200277 i 4500 |
| 001 |
NSK01000818739 |
| 003 |
HR-ZaNSK |
| 005 |
20140410153311.0 |
| 007 |
ta |
| 008 |
121003s2011 xxua 001 0 eng |
| 020 |
|
|
|a 9780873897976
|
| 035 |
|
|
|a (HR-ZaNSK)000818739
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 080 |
|
|
|a 615(73)
|2 MRF 1998.
|
| 080 |
|
|
|a 664(73)
|2 MRF 1998.
|
| 080 |
|
|
|a (73)
|2 MRF 1998.
|
| 100 |
1 |
|
|a Rodríguez-Pérez, José
|
| 245 |
1 |
0 |
|a CAPA for the FDA-regulated industry /
|c José Rodríguez-Pérez.
|
| 246 |
3 |
|
|a Corrective and preventive action for the FDA-regulated industry
|
| 260 |
|
|
|a Milwaukee :
|b ASQ,
|c 2011.
|
| 300 |
|
|
|a XIV, 147 str. :
|b ilustr. ;
|c 24 cm.
|
| 504 |
|
|
|a Bibliografija: str. 137-139 i uz tekst.
|
| 504 |
|
|
|a Kazalo.
|
| 650 |
|
7 |
|a Farmaceutska industrija
|z Sjedinjene Američke Države
|2 nskps
|
| 650 |
|
7 |
|a Prehrambena industrija
|z Sjedinjene Američke Države
|2 nskps
|
| 998 |
|
|
|m nmrk1210
|c mzoo121023
|
